Bruno Andrade

Dr. Bruno de Bezerril Andrade is a medical researcher focused on human immunology. He studies diagnostic and prognostic biomarkers associated with the pathogenesis of infectious diseases of great public health relevance. Graduated from the Federal University of Bahia (UFBA), with a Ph.D. in Human Pathology from the Oswaldo Cruz Foundation and a postdoctoral degree at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. He is currently a researcher at the Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, in Salvador, Bahia, as well as a professor of Medicine courses at UniFTC, UNIFACS, and at the postgraduate course at the Bahia School of Medicine and Public Health (EBMSP). He coordinates a multinational translational medicine group that merges experimental and clinical data to describe inflammatory pathways involved in the immunopathogenesis of diseases such as tuberculosis, HIV, viral hepatitis, arboviruses, malaria, leishmaniasis, and bacterial pneumonia. He leads a collaborative network of laboratories in South Africa (University of Cape Town), India (National Institute for Research in Tuberculosis), China (Henan Chest Hospital), and the United States (Vanderbilt University Medical Center and Johns Hopkins University School of Medicine), from where it develops studies to validate the results in places with different epidemiological profiles. Since 2019, he has been the coordinator of the Department of Statistics and Systems Biology of the Regional Prospective Observational Research for Tuberculosis (RePORT) International consortium and the principal investigator of this consortium in Brazil (RePORT Brasil). He is a member of the National Academy of Medicine (Young Leadership category), the Interacademy Medical Panel (Germany), of the Royal Society of Medicine (England), in addition to being a permanent member of the Collaboration for TB Vaccine Discovery (CTVD, Gates Foundation).